SCHEMBL3790601

SCHEMBL3790601

NCc1ccccc1-c1ccccc1N

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
L3MBTL1 Q9Y468 1/20 0.62
DPP4 P27487 3/20 0.59
HSD17B10 Q99714 2/20 0.46
PNMT P11086 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
IDO1 P14902 2/20 0.39
NOS3 P29474 1/20 0.37
NOS1 P29475 1/20 0.37
NOS2 P35228 1/20 0.37
KDM4E B2RXH2 3/20 0.37
NPC1 O15118 2/20 0.37
GAA P10253 2/20 0.37
ATR Q13535 1/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3787333 0.87 DPP4 (0.73) DPP4PNMTNOS3NOS1NOS2
SCHEMBL3793229 0.85 ALDH1A1 (0.54) ALDH1A1L3MBTL1DPP4HSD17B10PNMT
SCHEMBL3783728 0.81 ALDH1A1 (0.50) ALDH1A1L3MBTL1DPP4HSD17B10SMN1; SMN2
SCHEMBL3784711 0.81 ALDH1A1 (0.50) ALDH1A1L3MBTL1DPP4HSD17B10PNMT
SCHEMBL3785160 0.80 ALDH1A1 (0.48) ALDH1A1L3MBTL1DPP4HSD17B10PNMT
SCHEMBL307921 0.79
SCHEMBL32668885 0.79
SCHEMBL11550868 0.79 ALDH1A1 (0.59) ALDH1A1L3MBTL1HSD17B10SMN1; SMN2CYP3A4
SCHEMBL3794284 0.79 ALDH1A1 (0.59) ALDH1A1L3MBTL1DPP4HSD17B10SMN1; SMN2
SCHEMBL7560247 0.79 ALDH1A1 (0.59) ALDH1A1L3MBTL1DPP4HSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020058788-A1 Facile deprotection of Fmoc protected amino groups DISCOVERY PARTNERS INTERNATIONAL, INC. 2002-05-16 US claimed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed
US-20020103381-A1 Method for the synthesis of pyrazolines CHEMRX ADVANCED TECHNOLOGIES, INC. 2002-08-01 US disclosed
US-20020058788-A1 Facile deprotection of Fmoc protected amino groups DISCOVERY PARTNERS INTERNATIONAL, INC. 2002-05-16 US disclosed
WO-2001040193-A1 METHOD FOR THE SYNTHESIS OF PYRAZOLINES CHEMRX ADVANCED TECHNOLOGIES, INC. (US) 2001-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103381-A1 Method for the synthesis of pyrazolines CYP2F1, CYP2E1, CYP3A7 ALDH1A1 223/4885L3MBTL1 4833/4885DPP4 3417/4885
US-20020058788-A1 Facile deprotection of Fmoc protected amino groups DNPEP, LNPEP, NPEPPS ALDH1A1 3560/4885L3MBTL1 668/4885DPP4 315/4885
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 ALDH1A1 4339/4885L3MBTL1 3838/4885DPP4 3267/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.